FTO and leukemia: Because FTO deregulation appears in naïve and resistant clones, this mechanism could be applied to both earlier stage leukemia, where FTO provides cells with initial defense against TKI killing, and also the advanced leukemia, where higher levels of FTO offer cancer cells more advantages to proliferate and progress.